IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 48.68

Change

+0.19 (+0.39)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+0.28 (+0.20%)

USD 36.67B
FHLC Fidelity® MSCI Health Care In..

+0.19 (+0.29%)

USD 2.62B
FXH First Trust Health Care AlphaD..

+0.42 (+0.40%)

USD 1.09B
XHE SPDR® S&P Health Care Equipme..

+0.72 (+0.80%)

USD 0.21B
IDNA iShares Genomics Immunology an..

+0.13 (+0.57%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

+0.64 (+1.90%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

+0.68 (+0.75%)

USD 0.07B
HTEC Robo Global® Healthcare Techn..

+0.16 (+0.55%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

+0.69 (+1.13%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.42 (+1.71%)

USD 0.01B

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 9.38 % 0.00 %

+0.16 (+0.57%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.29% 5% F 21% F
Dividend Return 0.78% 56% F 9% A-
Total Return -6.51% 5% F 18% F
Trailing 12 Months  
Capital Gain -7.41% 5% F 21% F
Dividend Return 0.78% 56% F 10% F
Total Return -6.63% 5% F 19% F
Trailing 5 Years  
Capital Gain 20.73% 43% F 61% D-
Dividend Return 5.17% 63% D 13% F
Total Return 25.90% 48% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 6.07% 62% D 54% F
Dividend Return 6.70% 62% D 49% F
Total Return 0.63% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 21.72% 43% F 51% F
Risk Adjusted Return 30.85% 57% F 45% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.